Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ZIVO Bioscience, Inc. (ZIVO : NSDQ)
 
 • Company Description   
Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan.

Number of Employees: 10

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.94 Daily Weekly Monthly
20 Day Moving Average: 6,256 shares
Shares Outstanding: 9.42 (millions)
Market Capitalization: $27.69 (millions)
Beta: 0.15
52 Week High: $12.00
52 Week Low: $2.37
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.18% -9.26%
12 Week -19.45% -12.60%
Year To Date 2.44% 21.82%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
21 EAST LONG LAKE ROAD SUITE 100
-
BLOOMFIELD HILLS,MI 48304
USA
ph: 248-452-9866
fax: -
tpatel@lhai.com http://www.zivobioscience.com
 
 • General Corporate Information   
Officers
John B. Payne - Chief Executive Officer; President
Keith R. Marchiando - Chief Financial Officer; and Secretary
Christopher D. Maggiore - Director
Nola E. Masterson - Director
Alison A. Cornell - Director

Peer Information
ZIVO Bioscience, Inc. (CORR.)
ZIVO Bioscience, Inc. (RSPI)
ZIVO Bioscience, Inc. (CGXP)
ZIVO Bioscience, Inc. (BGEN)
ZIVO Bioscience, Inc. (GTBP)
ZIVO Bioscience, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 98978N200
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 05/16/22
Share - Related Items
Shares Outstanding: 9.42
Most Recent Split Date: 5.00 (0.01:1)
Beta: 0.15
Market Capitalization: $27.69 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/16/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.04
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 73.75%
vs. Previous Quarter: 25.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -144.91
12/31/21 - -391.40
09/30/21 - -
ROA
03/31/22 - -96.22
12/31/21 - -119.98
09/30/21 - -137.58
Current Ratio
03/31/22 - 2.52
12/31/21 - 3.04
09/30/21 - 3.42
Quick Ratio
03/31/22 - -
12/31/21 - 3.04
09/30/21 - 3.08
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 0.49
12/31/21 - 0.64
09/30/21 - 0.84
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©